Mr Matthew Zverev Zverev

Greenow, K. R., Zverev, M., May, S., Kendrick, H., Williams, G. T., Phesse, T. and Parry, L. 2018. Lect2 deficiency is characterised by altered cytokine levels and promotion of intestinal tumourigenesis. Oncotarget 9(92), pp. 36430-36443. (10.18632/oncotarget.26335)

Raja, M., Zverev, M., Seipel, K., Williams, G. T., Burnett, A. K., Clarke, A. R. and Shaw, P. 2015. Assessment of the in vivo activity of PI3K and MEK inhibitors in genetically defined models of colorectal cancer. Molecular Cancer Therapeutics 14(10), pp. 2175-2186. (10.1158/1535-7163.MCT-15-0223)

Greenow, K. R., Zverev, M., May, S., Kendrick, H., Williams, G. T., Phesse, T. and Parry, L. 2018. Lect2 deficiency is characterised by altered cytokine levels and promotion of intestinal tumourigenesis. Oncotarget 9(92), pp. 36430-36443. (10.18632/oncotarget.26335)
Raja, M., Zverev, M., Seipel, K., Williams, G. T., Burnett, A. K., Clarke, A. R. and Shaw, P. 2015. Assessment of the in vivo activity of PI3K and MEK inhibitors in genetically defined models of colorectal cancer. Molecular Cancer Therapeutics 14(10), pp. 2175-2186. (10.1158/1535-7163.MCT-15-0223)

Publication